Results Archives - PPM Healthcare

March 15, 2023

Google is making it easier to find low-cost healthcare centers in search results

At its wellbeing-concentrated party right now, Google announced a series of wellness updates for its goods, such as Research. Most notably, the firm declared that it’s creating it easier for people today to uncover inexpensive health care centers near them. The tech giant unveiled that you will before long be in a position to see companies that determine as group wellbeing centers featuring no cost or low-price treatment in look for benefits.

If a medical clinic presents cost-effective treatment, you will shortly see a label that reads “Free or small-charge care” underneath its identify in look for outcomes.

“You’ll be able to see info for group wellness centers in the U.S. that offer you free or small-charge treatment,” claimed Hema Budaraju, Google’s senior director of merchandise for overall health and lookup, through a briefing with reporters. “We’re focusing on these facilities because we know that the obtain they offer to primary treatment has been demonstrated to demonstrate effect in improving upon serious ailments, increasing the use of preventative providers and reducing ER visits. This knowledge on the group health facilities is dependent on publicly offered details from Overall health Sources and Companies Administration, which include all registered federally skilled overall health centers.”

Google also announced that it is creating it less complicated to find Medicaid re-enrollment facts less complicated to uncover on Look for. In the U.S., millions of men and women signed up for Medicaid all through the pandemic. At that time, the requirement to re-enroll just about every 12 months was paused, but that pause is about to expire on March 31, which means that if folks fail to re-enroll, they will shed their health care protection.

To assist individuals steer clear of this, Google is generating Medicaid re-enrollment information less complicated to come across on Research. Users will see what actions they need to just take by receiving entry to condition-distinct data about re-enrollment.

Image Credits: Google

Google mentioned that it’s working with new procedures to assure that Look for is connecting individuals with up-to-day information and facts. The business unveiled that its dialogue AI engineering, Duplex, has known as hundreds of health care providers in the U.S. to verify their information on Google Lookup. Google has also applied Duplex to verify if providers accept selected Medicaid plans in their state.

The tech big is also partnering with ThroughLine, a community of psychological health and fitness and crisis helplines all-around the world, to improve the variety of crisis helplines that look at the prime of lookup results in additional languages and nations around the world for queries relevant to suicide, domestic violence and other disaster matters.

Later this month, Google options to make more of Fitbit’s Overall health Metrics Dashboard element readily available with no a membership to men and women making use of Fitbit with suitable devices in nations around the world wherever the characteristic is offered. The attribute aids you uncover modifications with your respiratory level, pores and skin temperature, blood oxygen and much more. Google claims that with this update, buyers will be equipped to see traits over lengthier periods of time, even though also acquiring insights about what metrics modified from their baseline.

Google also announced that the material on the Harvard Health-related College Continuing Instruction YouTube channel is eligible for clinicians to declare towards their Continuing Clinical and Continuing Nursing Education credits. In addition, the organization is operating with the Accreditation Council for Continuing Healthcare Training to provide most effective techniques for video clip generation and information strategy that will support accrediting businesses develop even additional CME-eligible written content on YouTube.

March 6, 2023

Fit After 50 Reviews – Real Fitness Plan for Men or Fake Program Results? – Sponsored Content

Program Overview
Program Name:Fit After 50
Category: Fitness and Wellness workout program
Creator Of The Program: Mark Mcilyar.
Program Description: Fit After 50 is a detailed and effective fitness and wellness workout guide created by Mark Mcilyar in order to help men above the age of 50 to maintain their overall well-being.
Key Benefits

Helps you in losing weight.
Maintains your cardiovascular health.
Prevents muscle loss.
Boosts your energy levels.
Helps in gaining back your youthful glow.
Stimulates brain health.
Guarantee: 100{35112b74ca1a6bc4decb6697edde3f9edcc1b44915f2ccb9995df8df6b4364bc} 365 days money-back guarantee.
Price: Available at $37.
Official Website: Click Here

What Is Fit After 50 Program?

The Fit After 50 program is a fitness and wellness workout program specifically designed for individuals over the age of 50. The fitness program focuses on helping individuals maintain and improve their overall health and wellness through a combination of exercise routines, nutrition, and lifestyle changes.

The program includes a variety of different fitness routines and activities, such as strength training, cardiovascular exercise, flexibility and balance training, and more. The fitness program also includes a nutrition component that focuses on providing individuals with the necessary nutrients to support their health and fitness goals.

Additionally, the training program includes lifestyle changes and coaching to help individuals develop healthy habits and maintain their progress over time.

One of the key components of the Fit After 50 program is its emphasis on safety. The program is designed to take into account the unique needs and limitations of older adults, and the exercises and activities are modified accordingly to minimize the risk of injury.

Moreover, the program includes regular assessments to monitor progress and make any necessary adjustments to ensure that individuals are meeting their goals in a safe and sustainable way.

Another important aspect of the Fit After 50 program is its focus on community. The program is designed to be done in a group setting, which allows individuals to connect with others who are also working towards similar goals. This community aspect can be incredibly motivating and provides a sense of accountability and support for individuals as they work towards their goals.

About The Creators Of The Fit After 50 Program

Mark Mcilyar is the founder of the Fit After 50 program, a fitness, and wellness program specifically designed for individuals over the age of 50. With over 20 years of experience in the fitness industry, Mark is a highly experienced and qualified professional in the field of health and wellness. He is a certified personal trainer and has extensive knowledge in the areas of aging, exercise science, and nutrition.

Mark Mcilyar was inspired to create the Fit After 50 program after realizing that there were very few fitness options available for older adults that were safe and effective. He recognized that the needs of older adults are unique and require a different approach to fitness and wellness.

With this in mind, he developed the Fit After 50 program, which is designed to take into account the unique needs and limitations of older adults and provide them with a safe and effective way to improve their overall health and wellness.

Mark’s philosophy is to help older adults to age gracefully and maintain their independence. As a licensed healthcare provider, he believes that regular exercise, proper nutrition, and healthy lifestyle habits are the key to achieving this goal. Mark’s passion for helping older adults is evident in the Fit After 50 program, which is designed to empower older adults to take control of their health and live their best lives.

Mark Mcilyar is a dedicated and experienced professional who is committed to helping older adults improve their health and wellness. His program, Fit After 50, is a testament to his passion for helping older adults and his deep understanding of the unique needs of this population.

Mark’s program is a great choice for older adults who want to improve their health and wellness in a safe and sustainable way.

How Does Fit After 50 Program Work?

The Fit After 50 program works in three major stages. Through these stages, you experience a combination of metabolic strength training, cardio exercises, and recovery-centered exercises. Let’s take a brief skim through all three stages of the Fit After 50 fitness program.

Stage 1 – Burn
The first stage in Fit After 50 is to stimulate fat burning. On this level, you are recommended exercise methods that help you with weight loss. Once the extra body fat begins to fade out, the metabolic rate of your body improves a lot. Your digestive system makes sure that all the food is absorbed and that there is no fat accumulation in your blood vessels.

Stage 2 – Build
As the name suggests, this phase is all about building muscle mass. Once your body is free from all the unnecessary fat layers, you can begin the process of muscle building. The workout plans in this stage will need a lot of energy. To maintain your energy levels you can start by adding proteins to your daily diet. More protein ultimately means more muscle mass.

Stage 3 – Sculpt
The third and final phase of Fit After 50 is sculpting. In this stage, your body becomes all set to achieve a fit physique. After passing through the above two stages, you will have already started to experience improved stamina, healthy cardiovascular health, and enhanced blood flow. The sculpting exercises recommended for this stage are there to shape your muscle mass and make them more visible.

(Special Discount) Purchase Fit After 50 For The Lowest Prices Here!!

Why Is Improving T-Levels In The Body An Integral Aim Of Fit After 50 Fitness Programs?

As we get older, an array of lifestyle changes like reduced activity levels, more stress than usual, and other key factors result in lower T-Levels in the body. Unfortunately, as a result of declining testosterone levels, older adults may experience weight gain, decreased muscle mass, irregular sleep patterns, and overall lower fitness levels.

This section will look at why improving T-Levels in the body is an integral aim of the Fit After 50 Fitness Program.

Optimal T-Levels Help Promote Weight Loss
Testosterone is a hormone that plays an important role in weight loss. It helps to regulate metabolism, which is the process of breaking down food into energy. Testosterone also helps to increase muscle mass and strength, which can help with burning more calories and fat. Additionally, testosterone helps to reduce appetite and cravings for unhealthy foods, making it easier to stick to a healthy diet.

Optimal levels of testosterone are essential for successful weight loss. Low levels of testosterone can lead to decreased muscle mass, increased fat storage, and decreased metabolic rate. This can make it difficult to lose weight or maintain a healthy weight. On the other hand, higher levels of testosterone can help promote weight loss by increasing metabolism and reducing appetite.

Testosterone also has an effect on hormones that control hunger and satiety, such as ghrelin and leptin. Ghrelin is a hormone that increases hunger, while leptin is a hormone that decreases hunger. Higher levels of testosterone can help reduce ghrelin levels while increasing leptin levels, which can help reduce cravings for unhealthy foods and make it easier to stick to a healthy diet plan.

Testosterone Improves Muscle Mass
Testosterone is a hormone that plays an important role in promoting muscle mass. It is produced primarily in the testes and is responsible for the development of male characteristics, such as facial hair growth and deepening of the voice. Testosterone also helps to increase lean muscle mass by stimulating protein synthesis in the body.

This process helps to build new muscle fibers, which can lead to increased strength and size. Additionally, testosterone increases red blood cell production, which helps to deliver more oxygen and nutrients to muscles during exercise. This can help improve performance and reduce fatigue during workouts.

Finally, testosterone can help reduce body fat levels by increasing metabolic rate and decreasing appetite. All of these factors combined make testosterone an important hormone for promoting muscle mass and improving overall health.

Optimal Testosterone Levels Help Boost Energy Levels
Testosterone is an important hormone for men, especially as they age. Low testosterone levels can lead to a decrease in energy and vitality. Testosterone helps to regulate the body’s metabolism, which is responsible for converting food into energy. It also helps to maintain muscle mass, which is essential for maintaining strength and endurance. As men age, their testosterone levels naturally decline, leading to a decrease in energy and vitality.

Testosterone plays an important role in boosting energy levels in the body by increasing the production of red blood cells. Red blood cells are responsible for carrying oxygen throughout the body, providing it with the necessary fuel it needs to perform physical activities.

Testosterone also helps to increase muscle mass, which increases the body’s ability to burn calories more efficiently and use them as energy instead of storing them as fat.

In addition to its role in boosting energy levels, testosterone also has other benefits, such as improving mood and libido. It can help reduce stress levels and improve overall well-being by increasing feelings of happiness and contentment. Testosterone can also help improve bone density and reduce risk factors associated with heart disease.

What Are The Health Benefits Of Taking Fit After 50 Program?

That being said, now let’s discuss all the major health benefits of the fitness program.

Fit After 50 Can Help In Countering Hormonal Imbalance
The Fit After 50 helps individuals over the age of 50 counter hormonal imbalances through a combination of exercise, nutrition, and lifestyle changes. The program includes strength training exercises that can increase muscle mass, improve insulin sensitivity, and increase the body’s ability to burn fat, all of which can help in hormonal imbalance.

With specific workout plans, your T-levels get boosted, which ultimately helps your body to counter many health issues and maintain great energy levels.

Furthermore, the workout program includes a nutrition component that focuses on providing individuals with the necessary nutrients to support their health and fitness goals and promotes healthy eating habits that can help balance hormones.

Fit After 50 Can Trigger An Effective Weight Loss
Your metabolic rate decides many aspects of your health. As you age, your metabolism gets slow, which might trigger the unhealthy accumulation of fat layers like belly fat. The workout plan of Fit After 50 includes a metabolic strength training section through which you can improve your metabolism rate.

Once your digestive system is in good condition, your body will start to lose weight as it will shed and reduce body fat. Following the same process, your body will eventually achieve a healthy weight. Moreover, this entire process of burning fat and losing weight will also help you maintain your lean body structure.

Fit After 50 Might Boost Muscle Growth
The whole concept of muscle building sounds nearly dreamy when you are above the age of 50. But Fit After 50 has made it absolutely possible with the right guidance and routine. You can easily gain lean muscle mass and build muscles by following the recommended exercises that will help you in developing and strengthening your muscular system.

With just some regular exercises and a healthy diet, you can boost your testosterone levels which will ultimately prevent muscle loss and boost your stamina without using any heavy gym equipment.

Fit After 50 Can Bring Back The Youthful Glow
One of the major health benefits of Fit After 50 is that it helps you in gaining back your youth charm. It enhances your lean muscle mass, testosterone levels, and the mitochondrial role, which triggers the anti-aging process in your body. It also boosts your functional cardio and helps your body to build muscle that will add to your overall lean body look.

The Program Can Enhance Energy Levels
Boosting your energy levels is the primary focus of the Fit After 50 workout program. According to many Fit After 50 reviews present all over the internet, users have experienced an incredible boost in their overall body stamina by following the exercises prescribed by the program.

The ultimate weight loss in your body increases your lean muscles, making you feel punctual and giving your body more free movements.

Fit After 50 Might Stimulate Your Cardiovascular System And Improve Blood Pressure Levels

Your cardiovascular health is really important for your overall well-being. The accumulation of stubborn fat in your blood vessels can cause irregular blood circulation and ultimately lead to several health issues.

Though, the cardiovascular exercises recommended by the training guide can help you in improving your heart health. With a nutritional diet and regular exercises as instructed in the program, you trigger healthy weight loss which boosts testosterone levels in your body. This increase in T-levels doesn’t only help in healthy blood circulation but also in developing lean mass.

Moreover, the prescribed cardio exercise method helps in maintaining the problem of high blood pressure.

Fit After 50 Can Also Strengthen Your Memory And Brain Health

With a healthy weight loss, you are able to increase the testosterone levels in your body. This boost helps you in enhancing overall cognitive health. Hence, strengthens your memory power and brain health. In addition to it, as you lose weight with regular workouts, the blood flow in your body becomes better. That means oxygen is distributed equally to each of your organs, including your brain. Thus, improving its overall functioning.

Are There Any Bonus Products Offered With The Program?

The answer is YES. The Fit After 50 program comes with a set of three bonus gifts that are absolutely free and really effective.

Bonus 1 – 12 Week Fit After 50 Nutritional Plan
Personally designed by Mark Mcilyar, this nutritional plan promises to take your well-built body and performance to the next level. The pointers mentioned in this book can be easily applied to your daily diet. With an improved and healthy diet routine, you can lose weight and boost your testosterone levels.

Moreover, all the food recommendations mentioned here have been approved by the research and editorial team of the program.

Bonus 2 – Fit After 50 Exercise Illustrations And Execution Guide
If you are more of a visual learner, then this is a treat for you. Mark Mcilyar has created this visual workout plan in which you get step-by-step visuals for how to get the most out of every exercise method and not only increase your testosterone production but also improve your muscle gain.

Bonus 3 – Kown My T-Levels
Through this simple guide, you can learn all about your testosterone levels. For attaining a well-built body, you need to have healthy testosterone production in your body. This guide will act as a progress chart of your testosterone levels. You will be able to monitor your progress easily and spot all the exercise methods and food routine that has helped you throughout.

Now Or Never – Grab This Fit After 50 Offer Before Stock Runs Out!

How Is Fit After 50 Different From Other Similar Programs?

Indeed, there are a number of workout routines and guides similar to Fit After 50 available in the market. The following are the factors that make it better and more reliable than all of them.

Fit After 50 Comes With No Side Effects
It is very clear from the very beginning that Fit After 50 has no side effects. All the exercise routines recommended by it are completely safe and very effective. Unlike some exercise programs available in the health market, Fit After 50 has shown no negative side effects.

Fit After 50 Has a 100{35112b74ca1a6bc4decb6697edde3f9edcc1b44915f2ccb9995df8df6b4364bc} Money Back Guarantee
Your money is 100{35112b74ca1a6bc4decb6697edde3f9edcc1b44915f2ccb9995df8df6b4364bc} safe with the company. The founder of the program Mark Mcilyar ensures that you will notice major positive changes in your body within 7 to 10 days. Though, if you are not satisfied with the results, then you are free to call for a refund.

Unlike other training programs, Fit After 50 has a 365-day money-back guarantee.

Fit After 50 Prevents Muscle Loss
In addition to boosting the percentage of lean mass in your body, the diet, and exercises prescribed in the guide also helps you in losing unnecessary fat. The entire process helps boost your testosterone levels, ultimately boosting your muscle growth.

As compared to other guides in the market, Fit After 50 does its job effectively and quickly if followed religiously.

Are There Any Side Effects Of The Fit After 50 Program?

Mark Mcilyar’s Fit After 50 has no side effects. It is purely a strength training exercise guide that involves no secondary products, supplements, chemicals, or medicines that might cause any effect on your body.

From Where Should You Buy The Fit After 50 Program?
Fit After 50 is only available for purchase on its official website. The regular price of this amazing program is $97, but for a limited period of time, the company has reduced the price to just $37.

In addition to the recovery-focused workouts, you will also get three bonus gifts for free.

Is There A Money-Back Guarantee Offered With The Program?

The training program comes with a 100{35112b74ca1a6bc4decb6697edde3f9edcc1b44915f2ccb9995df8df6b4364bc} money-back guarantee. At any point in time, if you feel like the entire workout program is not providing you with the desired results, you can request a refund.

Furthermore, the duration for claiming the refund is 365 days (one year). If you see no progress after doing the recommended workout routines for at least two weeks, then you can freely contact the company for a refund. Your money is safe with the company and will be returned within a few business days.

What Does Fit After 50 Reviews Say About The Program?

There are many Fit After 50 reviews present all over the internet and its official website. It can be seen through them how the entire exercise routine has helped them in a more advanced way than any other fitness program could ever have.

According to all those Fit After 50 reviews, these age-specific exercises not only help in healthy weight gain but also boost testosterone levels and prevent sexual health disorders like erectile dysfunction.

Make It Count – Click Here To Secure The Exclusive Fit After 50 Offer Before Prices Go Up

What Else Can You Do To Stay Fit and Active Once You Hit 50?
It can be difficult to get in shape and stay fit after 50. Years of bad eating habits, lack of physical activity, and increased stress levels can have a negative impact on your overall health – especially as you get older. But it’s never too late to start living a healthier lifestyle! Here’s how people of age 50 and over can reduce their risk for chronic illness and stay fit:

Start Walking Every Day
Walking is one of the best forms of exercise for people over 50 because it gets your heart rate up while being gentle on your joints. Make it a daily habit of walking briskly around the block or at a local park every day. Try to increase your pace each time you go out – this will help you build up endurance as well as strength.

Maintain Healthy Eating Habits
Eating healthy foods that are low in saturated fat, sugar and sodium can help reduce your risk for chronic illnesses like diabetes, high blood pressure, stroke, and heart disease. Make sure to eat plenty of fresh fruits and vegetables, whole grains, lean proteins, and healthy fats such as olive oil. Also, stay away from processed food items and unhealthy snacks such as chips or candy bars.

Stretch Daily
Stretching helps maintain mobility by keeping muscles flexible and strong, helping you move with more ease even after years of sedentary living. Try practicing yoga or tai chi which are both calming yet effective ways to stretch your body while also building muscle strength gradually over time.

Create Goals: When motivation starts to slip as you age, setting goals can be a great way to keep yourself motivated and challenge yourself in various physical activities. Whether it’s a goal time for running a 5K or simply increasing one inch down on a push-up, these small achievements will inspire you to work harder each day and reach higher milestones than ever before.

Be Social
Being able to remain socially engaging is crucial as we age because it allows us to access our community resources which are essential in keeping us active & motivated with regular activities/ workouts regimen along with other senior members who experience similar issues during their battle with the aging process itself.

Having social contact prevents loneliness & promotes mental well-being since conversations help stimulate our brain cells & keep them active much longer than imagined earlier in scientific studies conducted from time immemorial by numerous medical professionals across the globe successfully today!

Final Verdict On Fit After 50 Program

Overall, the Fit After 50 program is a comprehensive approach to fitness and wellness that is specifically designed for older adults. The program includes a variety of exercises, a nutrition component, lifestyle coaching, and a focus on community and safety. It is a great option for individuals over the age of 50 who are looking to improve their overall health and wellness in a safe and sustainable way.

Don’t Wait Any Longer, Get Fit After 50 Program Right Now!!

ALSO READ:

Affiliate Disclosure:

The links contained in this product review may result in a small commission if you opt to purchase the product recommended at no additional cost to you. This goes towards supporting our research and editorial team. Please know we only recommend high-quality products.

Disclaimer:

Please understand that any advice or guidelines revealed here are not even remotely substitutes for sound medical or financial advice from a licensed healthcare provider or certified financial advisor. Make sure to consult with a professional physician or financial consultant before making any purchasing decision if you use medications or have concerns following the review details shared above. Individual results may vary and are not guaranteed as the statements regarding these products have not been evaluated by the Food and Drug Administration or Health Canada. The efficacy of these products has not been confirmed by FDA, or Health Canada approved research. These products are not intended to diagnose, treat, cure or prevent any disease and do not provide any kind of get-rich money scheme. Reviewer is not responsible for pricing inaccuracies. Check product sales page for final prices.

This article is sponsored content. No endorsement by The Times of Israel of advertiser products or services, real or implied, is intended. The Times of Israel editorial team did not contribute to this article.

January 10, 2023

Aspira Women’s Health Announces Preliminary Fourth Quarter 2022 Volume, Preliminary Results in Line with Cash Utilization Guidance, and Other Highlights

Aspira Women's Health Inc. — Aspira Women’s Wellness Inc.

Preliminary tests quantity in the course of the fourth quarter of 2022 was 5,643, an increase of 18 {35112b74ca1a6bc4decb6697edde3f9edcc1b44915f2ccb9995df8df6b4364bc} compared to the fourth quarter of 2021

Preliminary final results consistent with previously supplied dollars utilization direction for the fourth quarter and comprehensive yr of 2022

Additional lowered employees to realize anticipated 12 months-more than-year salary charge personal savings of about $6 million in 2023

AUSTIN, Texas, Jan. 09, 2023 (Globe NEWSWIRE) — Aspira Women’s Wellbeing Inc. (“Aspira”), a bio-analytical based women’s well being organization focused on the progress of gynecologic illness diagnostic applications, right now announced preliminary fourth quarter highlights.

Preliminary Fourth Quarter Highlights

The selection of OvaSuite^SM exams executed elevated 23{35112b74ca1a6bc4decb6697edde3f9edcc1b44915f2ccb9995df8df6b4364bc} to 21,424 assessments all through the year ended December 31, 2022, as opposed to 17,377 assessments in 2021.
The selection of OvaSuite checks carried out increased 18{35112b74ca1a6bc4decb6697edde3f9edcc1b44915f2ccb9995df8df6b4364bc} to 5,643 exams in the course of the quarter ended December 31, 2022, when compared to 4,768 checks for the fourth quarter of 2021.
Common day-to-day check volume reached a new superior in the fourth quarter, escalating to 86.6.
Preliminary benefits reveal that Aspira has reached previously offered dollars utilization steerage for the fourth quarter of concerning $6 million and 8 million.

Aspira President and CEO, Nicole Sandford, said, “This yr-more than-12 months increase in test quantity demonstrates steady provider adoption and the developing have faith in in our Ova1Plus® ovarian cancer threat assessment exam. To further accelerate the trajectory of our OvaSuite products portfolio in 2023, we have determined our most impactful product sales and promoting procedures and have built quick changes to our methods as a outcome. Territories have been expanded for our most helpful industry associates, and we prepare to generate additional superior-touch medical professional instructional opportunities based mostly on the OvaWatch medical review a short while ago revealed in Frontiers in Drugs . We are also using techniques to keep on to greatly enhance our partnership with BioReference adhering to the prosperous start of our co-advertising and distribution arrangement in the fourth quarter.”

Ms. Sandford ongoing, “We proceed to make progress on price tag containment, and preliminary effects display we comfortably satisfied our earlier furnished money utilization guidance for the fourth quarter and entire yr of 2022. Such as the pressure reduction we executed very last 7 days, we hope to save additional than $6 million dollars, in addition the charge of rewards, in 2023 relevant to redundant roles. We do not assume these reductions to have a substance effects on our development ideas. We imagine our current sources and incremental revenue will maintain the company by means of its solution innovation and development goals in 2023,” Ms. Sandford concluded.

About Aspira Women’s Overall health Inc.
Aspira Women’s Overall health Inc. is transforming women’s gynecological wellbeing with the discovery, development, and commercialization of progressive testing options for ladies of all races and ethnicities. OvaSuite is the company’s portfolio of blood-based mostly ovarian most cancers risk evaluation checks designed to enable healthcare providers move confidently from assessment to action for gals with adnexal masses. Ova1Plus combines our Food and drug administration-cleared solutions, Ova1^® and Overa^®, to detect hazard of ovarian malignancy in females with adnexal masses prepared for operation. OvaWatch^SM, a lab-formulated check with a 99{35112b74ca1a6bc4decb6697edde3f9edcc1b44915f2ccb9995df8df6b4364bc} Adverse Predictive Value, was built to rule out ovarian cancer threat in people with masses that appear benign or indeterminate dependent on the clinician’s preliminary evaluation. EndoCheck^TM, Aspira’s 1st-of-its-kind non-invasive diagnostic check for endometriosis, is now in growth. Visit our internet site for much more details at www.aspirawh.com.

Forward-On the lookout Statements
This push launch has ahead-on the lookout statements, as defined in the Personal Securities Litigation Reform Act of 1995, which include statements pertaining to strategic plans, development with respect to charge containment, believed examination volumes, estimated hard cash utilization for the fourth quarter and complete yr of 2022, hard cash means and anticipated financial savings and impacts from workforce reductions. Forward-seeking statements include a quantity of risks and uncertainties. Text these kinds of as “may,” “expects,” “intends,” “anticipates,” “believes,” “estimates,” “plans,” “seeks,” “could,” “should,” “continue,” “will,” “potential,” “projects” and comparable expressions are meant to determine ahead-on the lookout statements. These ahead-on the lookout statements talk only as of the date of this press release and are subject matter to a range of pitfalls, uncertainties and assumptions, together with those people described in the segment entitled “Risk Factors” in Aspira’s Once-a-year Report on Sort 10-K for the calendar year finished December 31, 2021, as supplemented by the part entitled “Risk Factors” in Aspira’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022. Amid other items, there can be no assurance that Aspira’s precise whole calendar year 2022 financial and operating effects will not differ, potentially significantly, from the preliminary money and functioning results contained in this press release. In addition, Aspira has not accomplished its fourth quarter and comprehensive year 2022 closing and evaluate approach, and the remaining effects for the whole year 2022 might vary, most likely considerably, from the statements designed in this press release. In the course of the training course of planning our 2022 money statements and throughout our evaluate method, we might detect things that would require us to make adjustments that may perhaps be substance to the quantities described in this press launch. Genuine success could also differ from all those contemplated by ahead-searching statements due to challenges which include, but not limited to: our skill to proceed as a heading issue our potential to comply with Nasdaq’s continued listing needs impacts resulting from potential modifications to coverage of Ova1 by our Medicare Administrative Carrier for Ova1 impacts ensuing from or relating to the COVID-19 pandemic and actions taken to consist of it anticipated use of money and its results our capacity to enhance the quantity of our product or service profits failures by third-occasion payers to reimburse for our solutions and services or modifications to reimbursement premiums our potential to continue building present systems and to develop, safeguard and boost our proprietary technologies designs to establish and complete laboratory made checks our capacity to comply with Foods and Drug Administration (“FDA”) restrictions that relate to our merchandise and to get any Fda clearance or acceptance demanded to develop and commercialize professional medical units our skill to acquire and commercialize extra diagnostic items and accomplish current market acceptance with regard to these goods our potential to compete successfully our skill to obtain any regulatory acceptance required for our foreseeable future diagnostic goods or our suppliers’ skill to comply with Fda demands for manufacturing, promoting and submit-sector monitoring of our items our skill to maintain adequate or satisfactory supplies of immunoassay kits from our suppliers in the occasion that we do well in commercializing our items outside the United States, the political, financial and other circumstances influencing other countries improvements in healthcare plan our ability to comply with environmental legislation our means to comply with the further legislation and polices that implement to us in connection with the operation of ASPiRA LABS our capability to use our internet running loss carryforwards our capacity to use mental residence our skill to effectively defend our proprietary technology versus 3rd parties our means to attain licenses in the celebration a third get together effectively asserts proprietary legal rights the liquidity and buying and selling quantity of our frequent inventory the concentration of ownership of our frequent stock our skill to retain crucial personnel our potential to secure further capital on appropriate conditions to execute our company system business enterprise interruptions the performance and availability of our data systems our capability to integrate and obtain anticipated success from any acquisitions or strategic alliances upcoming litigation versus us, which includes infringement of mental assets and merchandise liability publicity and more costs that could be needed to make even further enhancements to our laboratory functions. The gatherings and situations mirrored in Aspira’s forward-on the lookout statements may perhaps not be obtained or come about, and true results could vary materially from all those projected in the ahead-hunting statements. Aspira expressly disclaims any obligation to update, amend or clarify any ahead-looking statements irrespective of whether as a result of new info, long term occasions or in any other case, other than as needed by law.

Trader Relations Speak to:
Monique Kosse
Running Director
LifeSci Advisors, LLC
Tel: 212-915-3820

July 26, 2022

PetMed Express, Inc. (PETS) CEO Matthew Hulett on Q1 2022 Results – Earnings Call Transcript

PetMed Express, Inc. (NASDAQ:PETS) Q1 2022 Earnings Conference Call July 25, 2022 4:30 PM ET

Corporate Participants

Matthew Hulett – President and Chief Executive Officer

Bruce Rosenbloom – Chief Financial Officer

Conference Call Participants

Erin Wright – Morgan Stanley

Corey Grady – Jefferies

Anthony Lebiedzinski – Sidoti & Company

Operator

Welcome to the PetMeds Conference Call to Review the Financial Results for the First Fiscal Quarter Ended June 30, 2022. At the request of the company, this conference call is being recorded. Founded in 1996, PetMeds is your trusted pet health expert delivering prescription and nonprescription pet medications and other health products for dogs, cats, and horses direct to the customers. PetMeds’ markets its products through advertising and promotional campaigns, which directs customers to order online or by phone and which are intended to increase the recognition of the PetMeds brand name. PetMeds provides an attractive alternative for obtaining pet medication in terms of convenience, price, ease of ordering, and rapid home delivery.

At this time, I would like to turn the call over to the company’s Chief Financial Officer, Mr. Bruce Rosenbloom.

Bruce Rosenbloom

Thank you. And I’d like to welcome everybody here today. I would also like to remind everyone that the first portion of this conference call will be listen-only until the question-and-answer session, which will be later in the call. Also, certain information that will be included during this call may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 or the Securities and Exchange Commission that may involve a number of risks and uncertainties. These statements are based on our beliefs as well as assumptions we have used based upon information currently available to us. Because these statements reflect our current views concerning future events, these statements involve risks, uncertainties, and assumptions. Actual results could differ materially from those projected. The company undertakes no obligation to update these statements based on subsequent events. We have identified various risk factors associated with our operations in our most recent Annual Report and other filings with the Securities and Exchange Commission.

Now let me introduce our CEO and President, Matt Hulett. Matt?

Matthew Hulett

Thanks, Bruce. Good afternoon and thank you for joining us for our fiscal 2023 first quarter call. As a reminder, PetMeds pioneered the online pet prescription business over 26 years ago. And this is a legacy of which everyone at PetMeds is very proud. As I approach the one-year mark, since taking over as CEO and President, I continue to believe that PetMeds is a terrific company with a talented and dedicated workforce, serving a large and loyal customer base that supports our vision that every pet deserves to live a long, happy, healthy life.

My commitment to all of our stakeholders is to be open and transparent, particularly as it pertains to our progress with engineering the transformation of this iconic company. Today, I will break the call into four themes. One, an update on our core business; two, an update on our partner strategy; three, a major change to our management team; and four, the progress on our business transformation.

So let’s start with an update on our core business. As we mentioned in our last call, we saw a slow start to flea and tick season due to seasonally colder temperatures, which continued into the early part of the most recent quarter. Due to the high concentration of our business in flea and tick and heartworm medications, the slower sales of these products in the month of April in particular had a material impact on the quarter. Once warmer temperatures returned to much of the country, stimulating more normal flea and tick and heartworm medication demand from pet parents, we saw the expected rebound of a repeat base later in the back half of the quarter.

First quarter sales were 70.2 million compared to sales of 79.3 million for the same period the prior year. And while we are disappointed with the overall sales results for the quarter, we are encouraged by the sales generated from our returning base of customers in mid-May and June. Adjusted EBITDA for the first quarter was down 10{35112b74ca1a6bc4decb6697edde3f9edcc1b44915f2ccb9995df8df6b4364bc} year-over-year. We haven’t produced the results in net new customer growth but I remain optimistic that the combination of the new team, new media allocation and refreshed creative will start to stimulate profitable new customers.

Expanding from a business that was primarily optimized to market to existing customers to a business that also includes a focus on generating new customers will take some time. The slow start to our flea and tick season this spring also had an impact on our ability to attract new customers. There were simply fewer buyers for our seasonally sensitive product catalog. However, we did start to see improvements in new customer acquisition towards the end of the quarter.

We continue to invest in our infrastructure, including processes systems and people and you will note that general and administrative expenses increased on a year-over-year basis. These are very targeted investments which we strongly believe will grow long-term shareholder value. In fact, we have partnered with a number of well-seasoned third-party resources known and trusted by me and my team, particularly with regard to turnarounds to cost efficiently and quickly improve our ecommerce site delivery, usability testing, data analytics, capability and more. For instance, we have just enabled a new data warehouse that we call Pet House that gives us deep insights into our first party data that spans our 26 years.

On the marketing front, we’ve intentionally kept our variable marketing spin relatively flat year-over-year. Again, since April was slower due to unseasonably low temperatures, we determined that it wasn’t prudent to spend against lower demand. Our LTV to CAC number will be dynamic, but profitable as we test and learn. Our new customer count for the quarter was approximately 69,000 and our LTV to CAC for the quarter was 1.5.

To reiterate, we believe LTV to CAC is a more meaningful measure of the marketing value creation versus using PetMeds traditional [well as] [ph] metric. We expect to see this LTV to CAC number grow as we migrate more of our returning customers to our AutoShip subscription program. And as we expand average order value over the life of our customers.

Our AutoShip program continues to grow approximately 34{35112b74ca1a6bc4decb6697edde3f9edcc1b44915f2ccb9995df8df6b4364bc} of our revenue was recurring revenue derived from our AutoShip subscription program during the June quarter. We will be announcing some exciting new enhancements to our subscription program that we will address later on. During our last earnings call, we discussed our recent investment in partnership with Vetster, a pet telehealth company that connects pet parents with licensed veterinarian professionals all over North America.

Today, we are even more excited about this partnership and are making a ton of progress on our go-to-market and partner integration. I will spend more time detailing the progress later on this call. We are rapidly moving on the execution of our pet health expert strategy with the first building block of the strategic pillar being telemedicine. We have many other initiatives and partnerships underway that we plan to disclose at a future date.

Lastly, I would like to announce a significant new addition to the team and executive to the company. Over the last several quarters, we spent a great deal of time discussing our new strategy, processes, product and people. In terms of people, we have invested in an expanded leadership team that has experienced with both digital transformation and scaling a company. We have added several new executives in the last six months.

I am pleased and excited the latest member of my team Christine Chambers who officially joins us as PetMeds new Chief Financial Officer on August 3, you will get the chance to hear from Christine on our next call. As of course she will be participating in our earnings calls going forward. Christine is a seasoned finance professional with extensive experience transforming public and private companies. She was most recently the Chief Financial Officer at Real Networks. Prior to this, Christine and I worked together closely when she was the Senior Vice President of Finance at Rosetta Stone Incorporated. She has extensive and relevant experience that I am confident will help PetMed start to regain growing market share. And I’m personally delighted that Christine is joining our executive team.

The Board of Directors and I would like to thank Bruce Rosenbloom for his myriad of contributions to PetMeds for over 20 years. With an intense dedication to the company, Bruce has made a substantial impact as the Chief Financial Officer for over 20 years. The Board of Directors and all of the team members of PetMed thank him for his service. Bruce will be officially staying on for several months in a consultative capacity to ensure a smooth operational handoff. Thank you, Bruce for all you’ve done.

Now let us dive deeper into the details with the presentation material. As always, we’d like to feature pictures of our customers and employees pets in our slide decks. You will see many original pictures throughout this presentation. Starting with this slide which features my dog Harry, a pet meds customer since he was eight weeks old. Let us start with a look at the current market and our perspective on the overall opportunity.

As we covered in our previous earnings calls, PetMeds operates in a very large and growing addressable market. The total U.S. pet market is over 100 billion in annual sales and it is expected to reach 120 billion by 2024. The addressable pet medication market where we participate today is approximately 10 billion and also growing rapidly. We’re actively working on improving and growing our core business and that addressable market, while also setting our sights on expanding our addressable market into the broader wellness market, which is estimated to be over 30 billion.

Today, we are one of the leading and most trusted pet pharmacies. PetMeds is also an important part of the strategy of many of the pet platforms and players in the industry. As I have learned, there are not many truly reliable online prescription providers for these pet platforms and players to partner with, which puts us in an enviable position. Our core asset and demonstrated competency around prescriptions enables us to move much more quickly to execute on a broader pet health expert strategy.

We also operate in a market that is growing with underlying behavioral trends that are favorable to digital retailers, and it is a great time to be in a pet business. We also know that the pet vertical is more resilient than other verticals when there’s a financial downturn. In particular, it is a great time to be a retailer that is focused on essential consumables. U.S. household pet ownership has increased over time and today, seven out of 10 U.S. households have a pet. In a post-COVID world most pet parents are going to need and will seek out health and wellness care provided by a trusted brand. PetMed is uniquely positioned to take advantage of this trend.

Pet parents see their pets as an extension of their own families and they are increasingly demanding more healthy pet care options. We see this as a positive trend for PetMeds, and an opportunity for growth. Similarly, aligned with the trends in human health pet parents are thinking through the entire spectrum of their pets care from diet to veterinary services, and from infancy through old age. While some well-known retailers enter the market by means of pet food first, and then expand it, PetMed started first in the most difficult RX end of the market, and we are now expanding out. To that end, we intend to move much more aggressively this year in expanding our product assortment and catalog. We see significant compounding upside in the form of increasing recurring sales, increasing customer loyalty and increasing share of wallet by providing a broader non medication product assortment to pet owners.

Lastly, the pandemic accelerated the increasing trend for the digitization of healthcare. Specifically in the pet market regulations related to in person veterinarian visits and prescription fulfillment were temporarily waived for the first time during COVID. And these services moved online in unprecedented ways. PetMed is ahead of the curve on this trend with our strategic partnership and investment in pet telemedicine Vetster. With this groundbreaking partnership, we believe we are enabling the first real mainstream pet telemedicine platform and the one that will prove to be an accelerator of widespread adoption of pet telemedicine.

During the last earnings call, we discussed some key PetMed differentiators. I want to reiterate those because they are important and I believe they provide a real edge for a company’s transformation. First, our brand is both widely known and trusted. Our own market research indicates that 55{35112b74ca1a6bc4decb6697edde3f9edcc1b44915f2ccb9995df8df6b4364bc} of U.S. pet parents are aware of the PetMeds brand, having a strong brand takes years to develop and our customers look to PetMeds as their trusted pharmacy and pet medication expert. We will be leaning more into the brand in our external communication with more dynamic and relevant messaging and new channels to take advantage of our large brand goodwill.

Second, we have strong operational and quality efficiency as a pharmacy. The customer care integration with our pharmacy is world-class, which ensures that customers get their products delivered as promised quickly and accurately. Additionally, our vet partners reliably receive quality service delivered through our vet platform. We will be looking to expand our vet network and provide enhanced service to them with new technology delivered through our partnership with Vetster.

Our deep experience with the vet community is a significant competitive advantage. We have one of the largest direct to consumer vet networks in the online retail space with over 70,000 veterinarians that we have worked with over the company’s history. Currently our online vet portal has 17,000 active veterinarians and vet clinics. As I said in early earnings calls, this is a core capability and a unique asset because it enables us to expand our fulfillment capability as we scale our business.

Our intent is to drive incremental revenue through a powerful platform offering to our vet partners in the near future. We view vet as our partners in jointly providing a greater array of pet health services to pet parents, to that end we will continue working together holistically to improve that ability to care for pets. Ultimately, we believe if we help vets the profits for both the vets and for PetMeds will follow.

Our pet pharmaceutical category expertise is something I view as a towering strength. Many retailers can sell dog food but few can provide medication and sound health advice at scale. As I’ve said before, being a differentiated pet medication provider allows PetMeds to excel in our health and wellness offerings and continue to be viewed as trusted Pet Health experts especially as the market continues to become even more competitive.

PetMeds currently enjoys a close and strategic bond with our many supply partners, and those relationships have developed over time to become even more strategic. We have direct relationships with all of our major suppliers and have worked together closely to effectively market their products to our customer base. Our customer service and overall customer centricity ethos permeates our culture and is demonstrated throughout our team. We provide 100{35112b74ca1a6bc4decb6697edde3f9edcc1b44915f2ccb9995df8df6b4364bc} satisfaction guarantee, and we go the extra mile for our customers with truly empathetic and expert service. We don’t just have a transactional interaction with our customers, we have built trusting genuine relationships, our customers view PetMeds as a trusted pet health expert, and we take that responsibility seriously.

I recently had the pleasure of receiving an email directly from a customer concerning a phenomenal interaction with one of our Customer Care reps. Here’s what they had to say. Dear Mr. Hulett. The purpose of my letter is to bring your attention to my experience with a member of your team Jennifer, during my call with your company yesterday. Having the need to reorder Riley’s my dog monthly med, I called your company yesterday and was connected to Jennifer, for a knowledgeable professionalism and patience with me were outstanding. Being disabled without income and living on my savings. I had a lot of questions about different meds and the different ways I might be able to save some money. I’m sure my time with Jennifer probably extended past company policy regarding time, as most places you call, they rush you on and off the phone only wanting to take an order and get to the next customer. This was not the case. I had a lot of questions. And Jennifer was so patient and kind and assured me she was there to help me and that she was going to do it.

For time with me on the phone yesterday was at a great example of a dedication to PetMeds, and her love for helping others. I’m very impressed and thankful for her time and patience with me. Again, thank you for your company’s outstanding service. With the many different choices that are available to us to choose our med for our animals. I can tell you, it’s the folks like Jennifer that will keep them coming back. Should I have an opportunity to refer others be assured it’s PetMeds where I will be sending them to.

Jennifer is a perfect example of our employees dedication to our customers and their pets well being. And I’m delighted to share this story and recognize Jennifer and all of her colleagues for their exemplary customer service. PetMeds has historically been a somewhat low growth, yet high dividend-based company and we are proud to have created in return so much value to our shareholders. We are intent, however, upon becoming a higher growth company to create even more value, and we believe we are in a great position to do that. PetMeds is profitable with a pristine balance sheet. We do not have any debt. We have approximately 105.4 million in cash and cash equivalents as of June 30, 2022, and we are cashflow positive.

PetMeds is moving much of our business from a transactional direct-to-consumer model to a subscription business. subscription businesses are clearly compelling business models due to their predictable and stable recurring cash flows. As I mentioned at the beginning of the call, we ended the June quarter with approximately 34{35112b74ca1a6bc4decb6697edde3f9edcc1b44915f2ccb9995df8df6b4364bc} of our customers enrolled and ordering via our AutoShip and save subscription program. We continue to have a large base of returning customers, which is an indication of the quality service and the value that we deliver. We are fortunate to have a large base of 2 million pet parents that have purchased from us over the last two years.

We have over 26 years of experience as a pure play pet pharmacy, fully licensed in 50 states delivering outstanding service and value. This domain experience is what I would call the more complicated part of the pet ecosystem, which makes our progression into other segments much easier. Our customers just love our brand and our service. Our NPS score is over 80 which puts us in the upper quartile along with some of the most beloved brands in the world.

Now, I’d like to have Bruce review our financials for the quarter.

Bruce Rosenbloom

Thanks, Matt. During the review of our financial results, we will compare our first fiscal quarter which ended on June 30, 2022 to last year’s quarter that ended on June 30, 2021. I would also like to highlight that we introduced new non-GAAP financial metrics during our last fiscal year, adjusted EBITDA and adjusted EBITDA per share. We decided to include these new metrics because they are key measures used by management and by our Board to evaluate our operating performance, generate future operating plans and make strategic decisions regarding the allocation of capital.

Additionally, adjusted EBITDA and adjusted EBITDA per share, provide a more accurate picture of our underlying profitability and also take into account the more recent increases in non-cash stock-based compensation and other expenses. Throughout our most recent fiscal year, we faced a unique situation comparing two totally different environments between 2020 pandemic and 2021 mostly post-pandemic. As we move forward into our current fiscal year, the year ending March 31, 2023, with our new marketing partnerships, agencies and processes, we expect to be much more efficient with our variable marketing spend with improved results, and with many of our highlighted initiatives firmly in place.

For the current year, first quarter sales were 70.2 million, compared to sales of 79.3 million for the same period in the prior year, a decrease of 11.5{35112b74ca1a6bc4decb6697edde3f9edcc1b44915f2ccb9995df8df6b4364bc}. As Matt mentioned earlier, while we were disappointed with the sales decline year-over-year, we were encouraged by the sales trends we saw later in the June quarter. Reorder sales decreased by 7.8{35112b74ca1a6bc4decb6697edde3f9edcc1b44915f2ccb9995df8df6b4364bc} to 63.3 million for the quarter ended June 30, 2022, compared to reorder sales of 68.7 million for the same quarter the prior year, using a consistent 36-month definition of a new customer.

With the increasing AutoShips subscription adoption, we see more opportunities to continue to build our relationships with our loyal customer base. We will also look to continue to improve our reorder sales by marketing to our customer base with increased product offerings and services.

During the June quarter, we made a change to the methodology of how we calculate the percentage of revenue that was generated by our AutoShip and Save program. Going forward, we will report AutoShip net of discounts and credits. And we will also report the average of our AutoShip attainment over the quarter versus the last month of the quarter. Please note that this change to the calculation resulted in a decrease to the AutoShip percentage that was previously reported by only a few percentage points. We believe that this change reflects a more accurate representation of our subscription business for stakeholders to gauge its performance.

We are encouraged by the adoption of this program, and have seen an increasingly positive trend over the last several quarters since we launched this program. For example, our quarterly AutoShip percentage increased from 20{35112b74ca1a6bc4decb6697edde3f9edcc1b44915f2ccb9995df8df6b4364bc} in the December quarter to 31{35112b74ca1a6bc4decb6697edde3f9edcc1b44915f2ccb9995df8df6b4364bc} in the March quarter, and averaged 34{35112b74ca1a6bc4decb6697edde3f9edcc1b44915f2ccb9995df8df6b4364bc} for the most recent quarter ended June 30, 2022.

For the first quarter of fiscal 2023, our gross profit as a percentage of sales increased by approximately 95 basis points to 28.4{35112b74ca1a6bc4decb6697edde3f9edcc1b44915f2ccb9995df8df6b4364bc} compared to 27.5{35112b74ca1a6bc4decb6697edde3f9edcc1b44915f2ccb9995df8df6b4364bc} for the same period a year ago, as some of the major manufacturers shifted their funding from cooperative marketing rebates and discounting product costs to funding discount promotions, which support our AutoShip and Save subscription program. There may be an opportunity to improve gross margins in fiscal 2023, if the shift to prescription medications continue and we can grow future sales with appropriate price promotions.

Net income was 2.8 million or $0.14 diluted earnings per share for the first quarter of fiscal 2023 compared to 4.4 million or $0.22 diluted earnings per share to the same quarter last year. Adjusted EBITDA for the first fiscal quarter was 6.3 million, or $0.31 on a diluted basis compared to 7.1 million or $0.35 on a diluted basis for the same quarter last year.

Adjusted EBITDA and adjusted EBITDA per diluted share, add back certain non-cash expenditures, including stock compensation, interest income and expense, income taxes, depreciation and amortization and other expenses, like the investment banking fee related to the Vetster partnership. Again, adjusted EBITDA and adjusted EBITDA per share our non GAAP key measures used by management and our Board to evaluate our operating performance, generate future operating plans and make strategic decisions regarding the allocation of capital.

We will continue to disclose these financial measures in our future filings. As a result of the intentional and strategic investments in headcount and infrastructure made over the past year. We have seen double-digit percentage increases in general and administrative expenses. We strongly believe these investments are necessary for our transformation, and we intend to continue to make prudent investments in the business to fuel and support future growth.

In the June quarter, we spent approximately $982,000 in capital expenditures with the majority of the spend related to the customization of our ecommerce platform and our new data warehouse. We expect to see a continued investment in capital expenditures to the tune of approximately $4 million for the remainder of fiscal 2023, which will be utilized to further customize our ecommerce platform and IT infrastructure. We had 105.4 million in cash and cash equivalents and 22.6 million in inventory with no debt as of June 30, 2022.

The company continues to be committed to returning capital to our stockholders as such, the Board of Directors declared a quarterly dividend of $0.30 per share on the company’s common stock that will be payable on August 19, 2022, to shareholders of record at the close of business on August 12, 2022.

Also, please note that the declaration and payment of future dividends is discretionary and will be subject to a determination by the Board of Directors each quarter.

Now, I’d like to hand the presentation back over to Matt.

Matthew Hulett

During our last earnings call, we revealed our long-term strategy with some degree of specifics. PetMeds is moving from being just a leading pet medication retailer to being a market leader and expert pet healthcare. We envision a world where the majority of vet services and pet care move digitally. We’re in the early days of this digital transformation, but it is coming rapidly. We believe that a digitally enabled and data driven future will be the preferred mode of delivery for pet parents.

We have taken important steps towards executing on our long-term strategy, starting with our recent announcements that we’ve made in the telemedicine space. The strategic pillars that will be executing on are nutrition, medications, wellness and care with data both driving and being at the heart of our services. Our recent announcement with Vetster is the first building block of our care offering. During the last call, we discussed how this partnership is a real unlock in both technology and ecommerce integration which provides a powerful combination that has never been introduced in the pet category. We see a panoply of upsides and opportunities including first mainstream launch, we believe we’re the first company to introduce pet telemedicine to the mainstream connecting 2 million pet parent customers with over 70,000 veterinarians in the PetMeds network. Close the Loop, direct Connect access to a telemedicine experience that closes the loop between the pet parent and is that so that the prescription medication can be prescribed directly to a pet parents in many cases without the need of an in office visit new revenue streams. This partnership creates new revenue streams within PetMeds and the potential for new revenue streams from traffic driven from investors platform.

Go-to-market acceleration, unique investment in partnership terms allow pets to accelerate or go to market on our new strategy. For example, PetMeds will leverage the Vetster platform to provide virtual vet clinic services embedded with our pet medication and retail platform directly into their platform.

Climbing up the sales funnel, we believe that offering telehealth will enable us to acquire new customers and to create more incentives for PetMed subscribers. PetMeds customers will be able to get instant care whether that is via text or live video chat with your vet, or with any vet provider through an exclusive to that marketplace access on your smartphone or desktop 24/7.

Veterinary Alliance, we think that this partnership is a huge win for vets too. We believe this partnership will allow us to provide attractive capabilities and additional revenue streams and work flexibility to our core vet network and beyond. Since signing our agreement just several months ago, we have already moved very quickly towards integrating PetMeds and Vetster’s core technologies. We have already integrated two services in each other’s platform which include PetMeds integration.

PetMeds catalog Rx and ecommerce capability is now directly integrated into that stir. That means that now for any customer that has a direct veterinary relationship or resides in a state that allows for digital prescription fulfillment, any bet on investor will be able to triage, diagnose and then prescribe medication directly from a computer or mobile device. This level of integration happens directly as a virtual appointment. The data from the prescription and the overall appointment is integrated into the pet parents personal pet health dashboard. This innovation means that as virtual care increases for pets, PetMeds can become the engine that powers the ecommerce transaction behind this trend.

Vet Live is a new experience that we’ll be rolling out over the next several months. And the first of many services that we’ll be launching over the quarter. Vet Live is an exclusive veterinarian marketplace, integrated directly inside the PetMeds. Vet Live connects pet parents to 1000s of licensed veterinarians ready to provide the best online vet services through video chat appointments 24/7. I think about virtual care the way some entrepreneurs thought about the App Store as a potential to reach out to a global audience instantly. The companies that didn’t have the foresight to take advantage of a platform change like this missed out on a huge value unlock. Direct access to an exclusive network of extraordinary vet care providers is a very high engagement and high value proposition for pet parents. And we believe this will be a very sticky offering. And this is just one of many examples of how we believe we are building a very compelling platform for the next big trend in pet health.

We have made substantial and measurable progress on our transformation of the business over the last several quarters, and we remain laser focused on execution. Now that we have the majority of the new people process and strategic elements of the business underway, here’s what you can expect from us over the next couple of quarters in terms of our organic and inorganic growth focus.

Improvement in new customer growth. We will be expanding and accelerating our new customer acquisition efforts, which are critical to our long-term success. Continued migration of our business to a recurring subscription model. More active deployment of our capital. There are exciting opportunities for us to leverage capital to accelerate our transformation through investments, partnerships and acquisitions.

Full rollout of our pet telemedicine capability into the market. We will start to execute on the deployment and expansion of our integrations and partnership with Vetster. Expansion of product catalog and services. This includes a much wider product assortment, as well as adding more health and wellness services to our business.

Commitment to ESG. This year, we initiated our environmental, social and governance commitment. A great example of this is our Ukraine pet relief effort that we launched with IFA, as well as our longtime continued support of many U.S. based pet rescue and humane organizations. PetMeds firmly believes that we cannot consider ourselves successful as a business, if our team members, our communities, and our planet do not thrive as well.

Our strategy is still in the early stages of development at the heart of our commitment is getting back the pets, people in our planet. I can’t stress enough that it takes time to transform the company, especially in a highly competitive market and in an uncertain economic environment. But our market opportunity is clear and it is compelling. I’m confident that the foundation that we have been laying will meet that market opportunity in unique and innovative ways and will lead to increased operating results in shareholder value. PetMeds brand expertise and reputation are unparalleled. our balance sheet is strong. Our team is fantastic. And I am more excited about the future than ever. This ends our prepared remarks. Operator, we are now ready to take questions.

Question-and-Answer Session

Operator

Thank you. We will now be conducting a question-and-answer session. [Operator Instructions]. Thank you. Our first question is from Erin Wright with Morgan Stanley. Please proceed with your question.

Erin Wright

Hey, thank you for taking the questions. Can you give us an update on where we stand now with the flea and tick season? Were those sales just last or does it shift to the next quarter? And what are you seeing now on that front? And I think he used to give that quarterly seasonal weighting of what were considered seasonal products. I guess what does that cadence look like? Or what do you expected to look like this year compared to historical trends from a seasonal mix perspective? Thanks.

Matthew Hulett

Hi, Erin. This is Matt. Thanks for the question. Great to hear from you. A couple things about the quarter. It started out pretty slow, especially compared to March and we indicated that that March was slow due to seasonality around the temperatures being cold and it continued in April. And then it really progressively rebounded on our returning business through May through June and continues through July. So we’re pretty confident that parasiticide business of PetMeds is recovering very nicely. And that kind of maps to what we’ve seen in other supply chains and other partners that we’ve talked to.

And it’s very similar to what we’ve seen in subsequent historical practices in the business. Since we’ve been around for 26 years, we have some, a lot of data around this. To answer your question or point away, we use this as an extension to the season. It’s typically a six months season, we’re heavily weighted towards flea and tick and heartworm, and so we view the season being extended out versus contracting. Bruce, do you have any other follow up comments?

Bruce Rosenbloom

No, Matt. I think you covered everything there.

Erin Wright

Okay. Got it. Thanks. And then, more broadly, how are you thinking about pet spending in a tougher macro backdrop? And are you seeing any changes in customer behavior, for instance, in terms of trade down on products? Or pet owners moving from six months flea and tick packs to three months? Or has anything else changed or would be indicative of a change in consumer?

Matthew Hulett

Yes, Erin, great question. And we hope to change it in the future. As you know, we’re highly medication heavily Rx focused. And the good news about that is customers are very brand specific and brand loyal intend to not trade down. Maybe seen a little bit of impact on people trading down in terms of dosage, but not much. In the least this category, we’re seeing, not a lot of movement there. I think as we start thinking about broader consumable products, maybe food and other items, we’ll see some of that trade down. But in terms of brand loyalty to Rx, in particular, we have not seen a trade down behavior. Bruce anything to add there.

Bruce Rosenbloom

Historically when times have been tough, and again, I’ve been with the company’s through a few different downturns. You may see pet owners, instead of buying a six month supply, buying a three month supply, so a trading down from that perspective or stretching out that medication. We haven’t seen that yet. But that’s some behaviors we have seen in the past. So just something that we’ll keep tabs on, but as of right now, the data has not shown any significant changes.

Erin Wright

Okay. And one, just housekeeping question. Did you give new customer growth or total new customers acquired in the quarter?

Matthew Hulett

We did 59,000.

Erin Wright

Okay, got it. Thank you.

Matthew Hulett

You bet and add on to that Erin. And since we are still highly concentrated to Rx, particularly flea and tick and heartworm. April, just to be blunt, was not a great month to be acquiring those customers since the earth was pretty cold. So we were pretty, getting very optimistic actually, about our new customer acquisition initiatives underway, especially later in the quarter. So we expect to see good improvements throughout our calendar year and new customer acquisition. We’re getting more optimistic there.

Erin Wright

Okay, thank you.

Matthew Hulett

Thanks, Erin.

Operator

Thank you. Our next question comes from Corey Grady with Jefferies. Please proceed with your question.

Corey Grady

Hi. Thanks for taking my question. I wanted to follow up on your customer acquisition and ship initiatives. You tested new creative across the new channels during the quarter. Can you give us any more detail on results we’re seeing so far and where you are in terms of the marketing transformation?

Matthew Hulett

Hey, Corey. This is Matt. Thanks for your question. Thanks for hosting us recently in your conference. It was fantastic. I won’t go into the specific channels. But I think in a meta macro level, we’re definitely seeing rates get to more normal and/or in some cases, lower rates year-over-year, which is great news, which you typically see in some environments to get more macro challenge. But definitely on the performance marketing channels, we’re definitely seeing more stabilization, some cases, reduction of rates. Some channels are still high. I think we all know the issues around social but we’re definitely seeing a rationalization in rates is, I think growth oriented companies have readjusted how they think about their media mix. I think that is only going to be a net beneficiary for PetMeds.

And then that’s kind of the macro. The micro on us is, as you know, we spent some time talking about this app, PetMeds for a long time is focused on lower the funnel, aka performance marketing to its returning base. And since we had a new CMO and new partners starting about six months ago on a new strategy, we’ve definitely moved that shift to lean more into our brand and we’ve seen really strong results there. We expect those to continue and over this calendar year, we expect to see net new customer growth due to those efforts, and we’re feeling more optimistic about them. Did that answer your question, Corey?

Corey Grady

Yes, it did. It’s really helpful. And then for my second question, I just following up on the flea and tick, so given the known kind of flea and tick weakness coming into the quarter, how did reorder sales come in relative to your expectations? And then have you guys seen any change in seasonality to the vet industry that would typically precede a change in your reorder business?

Matthew Hulett

Yes, Corey, thanks. Thanks a lot for that. I will answer the first question first. With [indiscernible] April, how was I feeling about the quarter, I wouldn’t have been very optimistic, and then subsequently May and June got a lot more optimistic. So the quarter recovered to where we were expecting it to be and that continues into July on the returning side. Again, the new customer acquisition side was a little slow to warm up because the buyers weren’t there. And in terms of the vet cycle, we do tend to look a lot like the vet cycle, in terms of concentration of revenue. But also, the pattern for consumers with PetMeds is that the vet typically gets the first prescription and we get the secondary. We actually haven’t seen that as much as things are starting to recover that we are starting to see the similar cycles, even with the seasonality with colder temperatures. So don’t think that’s going to be much of a headwind for us as we come into this next quarter. Corey, I don’t know if that answered your question or not?

Corey Grady

It did. That’s helpful. Thank you.

Operator

[Operator Instructions] Our next question is from Anthony Lebiedzinski with Sidoti & Company. please proceed with your question.

Anthony Lebiedzinski

Yes, good afternoon. And thank you for taking the question. So as far as if I look at the traditional way of how PetMeds talk about advertising and new customer acquisition costs. So that was looks like about $92 for the quarter. How should we think about that number kind of going forward? I know, Matt, you’ve talked more about LTV to CAC. But I guess just for all us, old timers, we’ve covered the stock for a long time. How should we think about that on a go forward basis?

Matthew Hulett

Anthony, you’re referring to $92 is the absolute number for CAC.

Anthony Lebiedzinski

Right, yes. So if I take the advertising dollar amount divided by the number of new customers, which was just as close as far as 69,000, you said, so that comes out to $92?

Matthew Hulett

Yes. I just want to make sure we’re looking at the same sheet. In terms of the absolute number for CAC, we’re actually are feeling better about that, if you’re asking a directional question. So it’s been higher forces, my first stint as CMO for the business wasn’t the best quarter for CAC for the company. And we handed that to a more [impressive] [ph] CMO, but the CAC number for us is stabilized, it’s actually decreased a little bit due to this media mix. So on a go forward basis, we’re not thinking about and targeting CAC as a metric that we talk about. But since it’s easy to calculate, it’s actually been relatively stable and going down. The LTV number has been pretty stable as well. But we hope over time with recurring revenue and a broader catalog that just goes up because we get more opportunity to sell more products and get more engagement and a broad array of products. So I think LTV goes up over time.

And then I think right now Anthony, to answer your pointed question, I think $92 or maybe a little bit lower over time, it’s been going down as we’ve gotten smarter about our media mix. And also I think the current macro environment hasn’t been increasing as much which is worried us in the past. So I hope that’s helpful. We don’t pay good. I can’t predict what absolute number is going to be other than we’ve seen market improvement month-over-month, week-over-week and starting to stabilize in terms of price increases, so we’re feeling better about the CAC environment.

Anthony Lebiedzinski

Okay, that sounds good. Okay. So and I know it’s still early as far as a relationship with Vetster, but can you give us any sort of color as far as — I don’t know if you want to talk about the specifics, but as far as customers actually — your own customers using Vetster or vice versa. And Vetster customers using PetMeds to fill their orders, so can you give us any sort of additional color or details on that?

Matthew Hulett

Yes. And the first integration we did was to embed PetMeds as a private label inside of Vetster. Vetster is a startup. So really, they have a small amount of traffic right now. But it was a good “Watson Are You There” moment to determine whether it works or not, and A it works and B, customers are really delighted by the overall service. And I encourage everyone who’s listening to try, it’s really fantastic.

Secondarily, the big launch for us where the volume will start increasing and also getting more exposure on the site, and our mobile products will be Vet Live. And Vet Live will be the Vetster marketplace private labeled inside of our PetMeds properties. And that will come in the next several months, that’ll be the opportunity for us to really do some interesting things. The first part is just to engage with a pet telemedicine appointments live on the site. The secondary component is there’s a whole host of other sub services, we’re going to be launching, some will be an AutoShip, and the others will be extended from their current platform. But the first goal is to get, let’s say in the next several months Vet Live up to our current customers. And then we’ll start seeing a lot of a lot of usage there, Anthony.

So first things first, we launched in at work. The second point is PetMed should be getting that up live on our property in the next three months.

Anthony Lebiedzinski

Okay. And then lastly, for me, so unlike a lot of other consumer companies, where they’re dealing with bloated inventories, your actual inventory is lower than last year and lower than sequential basis. So that being said, I mean, do you feel like you have adequate inventory. Of course, there’s still ongoing supply chain issues that we’re hearing from other companies. So can you just talk about that as well?

Bruce Rosenbloom

Yes, Anthony. I’ll take that question. This is Bruce. Our inventory fluctuates from time-to-time, mostly due to opportunistic opportunities as far as buying. And we mentioned in the last call, at the end of the March quarter, we had an opportunity to take on additional inventory to reduce price. So we went ahead and pursued that. So we definitely were stocked up as of March 31. And sales, although recovering through the quarter, we’re still fairly slow in April. So I was saying the inventory levels where they are right now, around 22 million to 23 million, that’s probably a normalized level, maybe a little bit lower than maybe in past seasons, but not too long from where we’d like to be. And since we do have direct relationships with the manufacturers, lead times are cut really short based on how we used to procure. So no concern there, we are always going to be opportunistic, if there’s going to be enough that we have an opportunity to buy at a reduced cost. We’ll take advantage of that. And those usually come up usually traditionally at the end of the year, so around 12/31. So we’ll see how it shapes up. But there’s an opportunity. We’ll, take advantage of it.

Anthony Lebiedzinski

All right, terrific. All right. Thank you, Bruce. And thank you, Matt.

Matthew Hulett

Thanks, Anthony.

Operator

Thank you. Our question-and-answer portion of the call has ended. I would now like to turn the call back to Matt Hulett, the company CEO for his concluding remarks.

Matthew Hulett

Thank you, operator. As you just heard, the future of PetMed is much more expansive than just a prescription ecommerce company. We were building our strategy out and working hard to transform into a broader ecommerce and a subscription brand that reflects and leverages our status as a trusted pet health experts. I will continue to detail our progress and look forward to providing you with updates in the not too distant future. As always, thank you to all of our employees, customers, partners, suppliers, and investors for your continued confidence and support. Thank you for listening. And operator, this ends the conference call.

Operator

This concludes today’s conference. You may disconnect your lines at this time. Thank you for your participation.